|
[1] DUARTE S,BABER J,FUJII T,et al. Matrix metalloproteinases in liver injury,repair and fibrosis[J]. Matrix Biol,2015,44-46:147-156.
|
|
[2] SRIVASTAVA A,SHUKLA V,TIWARI D,et al. Targeted therapy of chronic liver diseases with the inhibitors of angiogenesis[J]. Biomed Pharmacother,2018,105:256-266.
|
|
[3] RIBERA J,PAUTA M,MELGAR-LESMES P,et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats[J]. Gut,2013,62(1):138-145.
|
|
[4] JACKSON DG. Leucocyte trafficking via the lymphatic vasculature-mechanisms and consequences[J]. Front Immunol,2019,10:471.
|
|
[5] ZHENG M,KIMURA S,NIO-KOBAYASHI J,et al. The selective distribution of LYVE-1-expressing endothelial cells and reticular cells in the reticulo-endothelial system?(RES)[J].Biomed Res,2016,37(3):187-198.
|
|
[6] TANAKA M,IWAKIRI Y. The hepatic lymphatic vascular system:Structure, function, markers, and lymphangiogenesis[J]. Cell Mol Gastroenterol Hepatol,2016,2(6):733-749.
|
|
[7] KITAGAWA K,NAKAJIMA G,KURAMOCHI H,et al. Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular carcinoma[J].Mol Clin Oncol,2013,1(6):1039-1048.
|
|
[8] ARIMOTO J,IKURA Y,SUEKANE T,et al. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers[J]. J Gastroenterol,2010,45(3):317-325.
|
|
[9] ELSIR T,SMITS A,LINDSTRM MS,et al. Transcription factor PROX1:Its role in development and cancer[J]. Cancer Metastasis Rev,2012,31(3-4):793-805.
|
|
[10] PARK KJ,CHO SB,PARK YL,et al. Prospero homeobox 1mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis[J]. Gastric Cancer,2017,20(1):104-115.
|
|
[11] DUDAS J,MANSUROGLU T,MORICONI F,et al. Altered regulation of Prox1-gene-expression in liver tumors[J].BMC Cancer,2008,8:92.
|
|
[12] SHIMODA M,TAKAHASHI M,YOSHIMOTO T,et al. A homeobox protein,prox1,is involved in the differentiation,proliferation,and prognosis in hepatocellular carcinoma[J]. Clin Cancer Res,2006,12(20 Pt 1):6005-6011.
|
|
[13] WEBER E,SOZIO F,BORGHINI A,et al. Pulmonary lymphatic vessel morphology:A review[J]. Ann Anat,2018,218:110-117.
|
|
[14] SUZUKI-INOUE K. CLEC-2/podoplanin and thromboinflammation[J]. Blood,2017,129(14):1896-1898.
|
|
[15] SCHACHT V,RAMIREZ MI,HONG YK,et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema[J]. EMBO J,2003,22(14):3546-3556.
|
|
[16] LINK A,HARDIE DL,FAVRE S,et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans[J]. Am J Pathol,2011,178(4):1662-1675.
|
|
[17] HSU MC,PAN MR,HUNG WC. Two Birds,one stone:Double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3[J]. Cells,2019,8(3):270.
|
|
[18] GAUDIO E,BARBARO B,ALVARO D,et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism[J]. Gastroenterology,2006,130(4):1270-1282.
|
|
[19] FRANCHITTO A,ONORI P,RENZI A,et al. Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases[J]. Hepatobiliary Surg Nutr,2013,2(2):68-77.
|
|
[20] WANG J,HUANG Y,ZHANG J,et al. NRP-2 in tumor lymphangiogenesis and lymphatic metastasis[J]. Cancer Lett,2018,418:176-184.
|
|
[21] KIM Y,HWANG SD,LIM JH,et al. Attenuated lymphatic proliferation ameliorates diabetic nephropathy and high-fat dietinduced renal lipotoxicity[J]. Sci Rep,2019,9(1):1994.
|
|
[22] SYED SN,JUNG M,WEIGERT A,et al. S1P provokes tumor lymphangiogenesis via macrophage-derived mediators such as IL-1βor Lipocalin-2[J]. Mediators Inflamm,2017,2017:7510496.
|
|
[23] KINASHI H,ITO Y,SUN T,et al. Roles of the TGF-β-VEGFC pathway in fibrosis-related lymphangiogenesis[J]. Int J Mol Sci,2018,19(9):2487.
|
|
[24] NAKAMOTO S,ITO Y,NISHIZAWA N,et al. Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemia-reperfusion injury[J]. Angiogenesis,2020,23(3):395-410.
|
|
[25] OHTANI O,OHTANI Y. Lymph circulation in the liver[J]. Anat Rec(Hoboken),2008,291(6):643-652.
|
|
[26] TAMBURINI B,FINLON JM,GILLEN AE,et al. Chronic liver disease in humans causes expansion and differentiation of liver lymphatic endothelial cells[J]. Front Immunol,2019,10:1036.
|
|
[27] CORPECHOT C,BARBU V,WENDUM D,et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis[J].Hepatology,2002,35(5):1010-1021.
|
|
[28] DA SILVA MEIRELLES L,MARSON RF,SOLARI M,et al. Are liver pericytes just precursors of myofibroblasts in hepatic diseases? Insights from the crosstalk between perivascular and inflammatory cells in liver injury and repair[J]. Cells,2020,9(1):188.
|
|
[29] SUN YY,LI XF,MENG XM,et al. Macrophage phenotype in liver injury and repair[J]. Scand J Immunol,2017,85(3):166-174.
|
|
[30] GUILLOT A,TACKE F. Liver macrophages:Old dogmas and new insights[J]. Hepatol Commun,2019,3(6):730-743.
|
|
[31] CHENG MX,LI JZ,CHEN Y,et al. VEGF-C attenuates ischemia reperfusion injury of liver graft in rats[J]. Transpl Immunol,2019,54:59-64.
|
|
[32] BURCHILL MA,GOLDBERG AR,TAMBURINI B. Emerging roles for lymphatics in chronic liver disease[J]. Front Physiol,2019,10:1579.
|
|
[33] ALLAIRE M,RAUTOU PE,CODOGNO P,et al. Autophagy in liver diseases:Time for translation?[J]. J Hepatol,2019,70(5):985-998.
|
|
[34] CORLISS BA,AZIMI MS,MUNSON JM,et al. Macrophages:An inflammatory link between angiogenesis and lymphangiogenesis[J]. Microcirculation,2016,23(2):95-121.
|
|
[35] LUKACS-KORNEK V. The role of lymphatic endothelial cells in liver injury and tumor development[J]. Front Immunol,2016,7:548.
|
|
[36] TANAKA M,IWAKIRI Y. Lymphatics in the liver[J]. Curr Opin Immunol,2018,53:137-142.
|
|
[37] XU H,ZHOU Y,LU C,et al. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting Rho A signaling pathway[J].Lab Invest,2012,92(12):1738-1748.
|
DownLoad: